Diphtheria Toxin-Epidermal Growth Factor Fusion Protein DAB(389)EGF for the treatment of bladder cancer

PURPOSE: The novel fusion protein, DAB(389)EGF, is comprised of both the catalytic and translocation domains of diphtheria toxin that are fused to the human epidermal growth factor, providing a targeting and a toxicity component. We tested DAB(389)EGF for anti-tumor activity in both in vitro and in...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Yang, Xiaoping, Kessler, Elizabeth, Su, Lih-Jen, Thorburn, Andrew, Frankel, Arthur E., Li, Yuan, La Rosa, Francisco G., Shen, Jingping, Li, Chuan-Yuan, Varella-Garcia, Marileila, Glodé, L. Michael, Flaig, Thomas W.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537889/
https://ncbi.nlm.nih.gov/pubmed/23172881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1258
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items